Median age, years (range) | 68.0 (46–83) |
Sex (male/female) | (36/15) |
Median distance from anal verge, cm (range) | 5.43(3–11) |
Neoadjuvant therapy | 22 (43.1%) |
Chemoradiotherapy | 18 |
Chemotherapy | 2 |
Total neoadjuvant therapy | 2 |
Diversion ileostomy or colostomy (%) | 46 (90.2) |
Lateral pelvic lymph node dissection (%) | 11 (21.6) |
Total operative time, min (range) | 283.1 (144–439) |
Estimated blood loss, mL (range) | 84.6 (10–450) |
Distal margin, cm (range) | 2.2 (0.5–5.7) |
Postoperative complication (%) | 3 (5.9) |
Clavien-Dindo ≥ 3 | 0 |
Anastomotic leakage | 0 |
Mortality | 0 |
Recurrence (Stage I-III) (%) | 2 (4.1%) |